Investigation of decreased availability of nitric oxide precursor as the mechanism responsible for impaired endothelium-dependent vasodilation in hypercholesterolemic patients
PR Casino,
CM Kilcoyne,
AA Quyyumi,
JM Hoeg,
and
JA Panza
Cardiology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland 20892.
OBJECTIVES. The purpose of this study was to determine whether the impaired endothelium-dependent vasodilation of hypercholesterolemic patients is due to decreased availability of L-arginine, the substrate for nitric oxide. BACKGROUND. Patients with hypercholesterolemia have impaired endothelium-dependent vasodilation that is related to a defect in the endothelium-derived nitric oxide system. However, the precise location of this abnormality has not been determined. METHODS. The study included 12 hypercholesterolemic patients (6 men, 6 women; 52 +/- 9 years old; serum cholesterol > 240 mg/dl) and 15 normal volunteers (8 men, 7 women; 50 +/- 6 years old; serum cholesterol < 210 mg/dl). The forearm vascular responses to intraarterial infusion of acetylcholine, an endothelium-dependent vasodilator (7.5, 15, 30 micrograms/min), and sodium nitroprusside, a direct smooth muscle dilator (0.8, 1.6, 3.2 micrograms/min) were studied before and during infusion of L- or D-arginine (a stereoisomer of arginine that is not a nitric oxide precursor). RESULTS. The response to acetylcholine was lower in hypercholesterolemic patients than in control subjects. However, no significant difference was observed with sodium nitroprusside infusion. L-Arginine augmented the response to acetylcholine in normal subjects (maximal blood flow increased from 14.4 +/- 7 to 18.9 +/- 10 ml/min per 100 ml, p < 0.002). In contrast, in the hypercholesterolemic patients, only a mild but not significant improvement in the response to acetylcholine was observed with the infusion of L-arginine (maximal blood flow increased from 6.8 +/- 4 to 8.4 +/- 5 ml/min per 100 ml; p = 0.16); however, a similar mild but not significant change was also observed with D-arginine (maximal blood flow increased from 6.8 +/- 4 to 8.3 +/- 4 ml/min per 100 ml, p = 0.07). L-Arginine did not modify the response to sodium nitroprusside in either group. CONCLUSIONS. The augmentation of endothelium-dependent vasodilation by L-arginine, the nitric oxide precursor, is defective in hypercholesterolemic patients. This supports the concept of an abnormal endothelium-derived nitric oxide system in hypercholesterolemia and indicates that decreased availability of nitric oxide substrate is not responsible for the impaired endothelial function in this condition.
This article has been cited by other articles:

|
 |

|
 |
 
M. A. Ozkor, J. R. Murrow, A. M. Rahman, N. Kavtaradze, J. Lin, A. Manatunga, and A. A. Quyyumi
Endothelium-Derived Hyperpolarizing Factor Determines Resting and Stimulated Forearm Vasodilator Tone in Health and in Disease
Circulation,
May 24, 2011;
123(20):
2244 - 2253.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D Tousoulis, C Xenakis, C Tentolouris, G Davies, C Antoniades, T Crake, and C Stefanadis
Effects of vitamin C on intracoronary L-arginine dependent coronary vasodilatation in patients with stable angina
Heart,
October 1, 2005;
91(10):
1319 - 1323.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Galle, A. Mameghani, S.-S. Bolz, S. Gambaryan, M. Gorg, T. Quaschning, U. Raff, H. Barth, S. Seibold, C. Wanner, et al.
Oxidized LDL and its Compound Lysophosphatidylcholine Potentiate AngII-Induced Vasoconstriction by Stimulation of RhoA
J. Am. Soc. Nephrol.,
June 1, 2003;
14(6):
1471 - 1479.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Komatsu, T. Kawagishi, M. Emoto, T. Shoji, A. Yamada, K. Sato, M. Hosoi, and Y. Nishizawa
ecNOS gene polymorphism is associated with endothelium-dependent vasodilation in Type 2 diabetes
Am J Physiol Heart Circ Physiol,
August 1, 2002;
283(2):
H557 - H561.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. J. Maxwell, M. P. Zapien, G. L. Pearce, G. MacCallum, and P. H. Stone
Randomized trial of a medical food for the dietary management of chronic, stable angina
J. Am. Coll. Cardiol.,
January 2, 2002;
39(1):
37 - 45.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. M Dart and J. P.F Chin-Dusting
Lipids and the endothelium
Cardiovasc Res,
August 1, 1999;
43(2):
308 - 322.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Kusterer, T. Pohl, H.-P. Fortmeyer, W. Marz, H. Scharnagl, A. Oldenburg, S. Angermuller, I. Fleming, K. H. Usadel, and R. Busse
Chronic selective hypertriglyceridemia impairs endothelium-dependent vasodilatation in rats
Cardiovasc Res,
June 1, 1999;
42(3):
783 - 793.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D Tousoulis, C Tentolouris, T Crake, G Katsimaglis, C Stefanadis, P Toutouzas, and G J Davies
Effects of L- and D-arginine on the basal tone of human diseased coronary arteries and their responses to substance P
Heart,
May 1, 1999;
81(5):
505 - 511.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
A. A. Quyyumi
Does acute improvement of endothelial dysfunction in coronary artery disease improve myocardial ischemia?: A double-blind comparison of parenteral D- and L-Arginine
J. Am. Coll. Cardiol.,
October 1, 1998;
32(4):
904 - 911.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. G. Diodati, N. Dakak, D. M. Gilligan, and A. A. Quyyumi
Effect of Atherosclerosis on Endothelium-Dependent Inhibition of Platelet Activation in Humans
Circulation,
July 7, 1998;
98(1):
17 - 24.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Dakak, S. Husain, D. Mulcahy, N. P. Andrews, J. A. Panza, M. Waclawiw, W. Schenke, and A. A. Quyyumi
Contribution of Nitric Oxide to Reactive Hyperemia : Impact of Endothelial Dysfunction
Hypertension,
July 1, 1998;
32(1):
9 - 15.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. P Noon, B. R Walker, M. F Hand, and D. J Webb
Impairment of forearm vasodilatation to acetylcholine in hypercholesterolemia is reversed by aspirin
Cardiovasc Res,
May 1, 1998;
38(2):
480 - 484.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Zhao and R. L. Tackett
Oxidized Low-Density Lipoprotein Inhibits Acetylcholine-Induced Vasorelaxation and Increases 5-HT-Induced Vasoconstriction in Isolated Human Saphenous Vein
J. Pharmacol. Exp. Ther.,
February 1, 1998;
284(2):
637 - 643.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
G. O'Driscoll, D. Green, and R. R. Taylor
Simvastatin, an HMG Coenzyme A Reductase Inhibitor, Improves Endothelial Function Within 1 Month
Circulation,
March 4, 1997;
95(5):
1126 - 1131.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
R. W. Jeremy, H. McCarron, and D. Sullivan
Effects of Dietary L-Arginine on Atherosclerosis and Endothelium-Dependent Vasodilatationin the Hypercholesterolemic Rabbit: Response According to Treatment Duration, Anatomic Site, and Sex
Circulation,
August 1, 1996;
94(3):
498 - 506.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
S. M. Bode-Boger, R. H. Boger, H. Alfke, D. Heinzel, D. Tsikas, A. Creutzig, K. Alexander, and J. C. Frolich
L-Arginine Induces Nitric Oxide Dependent Vasodilation in Patients With Critical Limb Ischemia : A Randomized, Controlled Study
Circulation,
January 1, 1996;
93(1):
85 - 90.
[Abstract]
[Full Text]
|
 |
|
|